PROFUND ADVISORS LLC

Position in OCUL — Ocular Therapeutix, Inc

CIK 1129919 BETHESDA, MD

Position in OCUL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$326,033

+$90,991 QoQ

Shares Held

33,201

+19.6% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#152

of 257 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. OCUL ranks #128 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$326,033	33,201	+19.6%	Shares	Sole	2026-08-11
2026-03-31	$235,042	27,750	+40.1%	Shares	Sole	2026-04-27
2025-12-31	$240,481	19,809	-21.3%	Shares	Sole	2026-02-06
2025-09-30	$294,330	25,178	+9.9%	Shares	Sole	2025-11-06
2025-06-30	$212,567	22,906	+43.9%	Shares	Sole	2025-08-07
2025-03-31	$116,642	15,913	-22.5%	Shares	Sole	2025-05-08
2024-12-31	$175,249	20,521	-8.2%	Shares	Sole	2025-02-14
2024-09-30	$194,505	22,357	-48.2%	Shares	Sole	2024-11-14
2024-06-30	$295,364	43,182	+263.9%	Shares	Sole	2024-08-13
2024-03-31	$107,998	11,868	-43.0%	Shares	Sole	2024-05-08
2023-09-30	$65,396	20,827	+94.1%	Shares	Sole	2023-11-13
2023-06-30	$55,356	10,728	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.